InvestorsHub Logo
Followers 172
Posts 17650
Boards Moderated 0
Alias Born 03/02/2012

Re: OCKHAM'S RAZOR post# 25696

Thursday, 03/26/2020 2:24:26 PM

Thursday, March 26, 2020 2:24:26 PM

Post# of 27500
People jumping on IMUN .0075... lots of good potential with their pipeline and for COVID-19!

Check her out!

Lodonal is their flagship drug. If they get FAST TRACK on this, the PPS will soar. Probably a long shot, but many will get a piece of this just in case. That's what's been happening with other stocks. Trade carefully here! What has spiked UP has also spiked down!

https://finance.yahoo.com/news/immune-therapeutics-inc-collaborate-cytocom-133000994.html

Clinical Mechanism of Action

Lodonal™ exerts its effects on humans via at least two distinct receptor mechanisms. The first receptor mechanism is the blocking of the opiate receptor for a short period time. This results in a reactive increase in the production of opioid receptors on immune cells,an increase in circulating levels of endorphins and enkephalins. Increased levels of beta-endorphin and enkephalins have been shown to stimulate the immune system, promoting an increase in the number and functions of T lymphocytes and natural killer (NK) cells. The increase in the T-cell and NK cell numbers and functions appears to restore a more normal balance of the immune cells such that effects of disease are significantly reduced.

It has been demonstrated in phase II clinical trials for Crohn’s Disease, HIV/AIDS, Fibromyalgia, MS, Autism and Cancer that in the presence of LDN, the numbers of T-cells, both CD4+ helper T cells and CD8+ cytotoxic T cells, may increase by more than 300%.


ImQUEST video... WOW!

http://imquestbio.com/programs/imquestsuccess/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.